cannabis indica

Índice completo — página 59 de 77

Estudos 5.801 a 5.900 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2014. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.801 a 5.900

  1. 2014

    Fetal cannabinoid receptors and the “dis-joint-ed” brain

    DesfavorávelEstudo em AnimaisGestaçãoAlterações Cerebrais NeonataisTetraidrocanabinol (THC)
  2. 2014

    Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22

  3. 2014

    Geraniol Blocks Calcium and Potassium Channels in the Mammalian Myocardium: Useful Effects to Treat Arrhythmias

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Arritmias Cardíacas
  4. 2014

    Geraniol-a Flavoring Agent With Multifunctional Effects in Protecting the Gastric and Duodenal Mucosa

  5. 2014

    Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond

  6. 2014

    Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder

    InconclusivoEnsaio Clínico Duplo-CegoTranstornos de ComportamentoAutismoProteína Ligadora de Ácidos Graxos (FABP)
  7. 2014

    Harnessing neuroendocrine controls of keratin expression: a new therapeutic strategy for skin diseases?

  8. 2014

    Harnessing the anti-inflammatory potential of palmitoylethanolamide

  9. 2014

    How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDependência — CannabisAnsiedadeTHC Farmacêutico+5
  10. 2014

    Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway

  11. 2014

    Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDisfunção CognitivaTetraidrocanabinol (THC)+2
  12. 2014

    In vitro antibacterial activity of Cannabis sativa leaf extracts to some selective pathogenicbacterial strains.

    FavorávelEstudo LaboratorialInfecções BacterianasDesequilíbrio do Microbioma
  13. 2014

    In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects

  14. 2014

    Increase in the Number of CB1 Immunopositive Neurons in the Amygdaloid Body after Acute Cold Stress Exposure

    DesfavorávelEstudo em AnimaisExposição ao Frio
  15. 2014

    Increase in the Number of CB1 Immunopositive Neurons in the Amygdaloid Body after Acute Cold Stress Exposure

    FavorávelEstudo em AnimaisMedicina Mente-Corpo
  16. 2014

    Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects

  17. 2014

    Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.

    FavorávelEstudo LaboratorialCâncerCâncer — Cólon
  18. 2014

    Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome.

    FavorávelMetanáliseAVCImunodeficiência por Trauma
  19. 2014

    Intestinal Fatty Acid Binding Protein (I-FABP) as a Promising Test for Crohn's Disease: A Preliminary Study

  20. 2014

    Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat.

    FavorávelEstudo em AnimaisApneia do SonoTHC Farmacêutico
  21. 2014

    Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain

    FavorávelEstudo em AnimaisDorDor — Aguda
  22. 2014

    Is recent cannabis use associated with acute coronary syndromes? An illustrative case series

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)Infarto+1
  23. 2014

    Is there a role for palmitoylethanolamide in the treatment of depression?

    FavorávelMetanáliseDepressãoPalmitoiletanolamida (PEA)
  24. 2014

    Ischemic stroke after use of the synthetic marijuana "spice"

  25. 2014

    Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  26. 2014

    Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.

  27. 2014

    Long-term consequences of perinatal fatty acid amino hydrolase inhibition

  28. 2014

    Marijuana and lung diseases

    DesfavorávelMetanáliseCâncerCâncer — PulmãoBronquite
  29. 2014

    Marijuana Use and Maternal Experiences of Severe Nausea During Pregnancy in Hawai‘i

    DesfavorávelMetanáliseNáusea e VômitoGestaçãoEnjoo Matinal na Gestação
  30. 2014

    Mechanism of platelet activation induced by endocannabinoids in blood and plasma

  31. 2014

    Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010

    FavorávelMetanáliseDependência — Opioides
  32. 2014

    Medical Marijuana Laws and Suicides by Gender and Age

    FavorávelMetanáliseTentativa de Suicídio
  33. 2014

    Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report

  34. 2014

    Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament

  35. 2014

    Modulation of Gut-Specific Mechanisms by Chronic Δ9-Tetrahydrocannabinol Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis.

    FavorávelEstudo em AnimaisHIV/AIDSTetraidrocanabinol (THC)
  36. 2014

    Molecular basis for the improvement in muscle metaboreflex and mechanoreflex control in exercise-trained humans with chronic heart failure

  37. 2014

    Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome

  38. 2014

    Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses

  39. 2014

    N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoDoenças de PelePruridoAnandamida (AEA)Palmitoiletanolamida (PEA)+1
  40. 2014

    Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaEsclerose MúltiplaTetraidrocanabinol (THC)THC Farmacêutico+1
  41. 2014

    Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting

  42. 2014

    Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial

  43. 2014

    Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration

  44. 2014

    No opiates against cannabis hyperemesis syndrome

    DesfavorávelMetanáliseDependência — OpioidesSíndrome da Hiperêmese Canabinoide
  45. 2014

    Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease.

    FavorávelEstudo em AnimaisDoença de ParkinsonOleoiletanolamida (OEA)
  46. 2014

    Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking

    DesfavorávelEnsaio ClínicoDependência — CannabisCanabinol (CBN)
  47. 2014

    Palmitoylethanolamide in CNS health and disease

  48. 2014

    Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features

    InconclusivoEstudo LaboratorialCâncerCâncer — LinfomaHidrolase de Amidas de Ácidos Graxos (FAAH)
  49. 2014

    Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs

  50. 2014

    Pharmacotherapies for cannabis dependence

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — Cannabis
  51. 2014

    Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review

    FavorávelMetanáliseTricotilomaniaTHC Farmacêutico
  52. 2014

    Physical activity and the endocannabinoid system: an overview

    FavorávelMetanáliseExercício Físico
  53. 2014

    Phytol, a Diterpene Alcohol from Chlorophyll, as a Drug against Neglected Tropical Disease Schistosomiasis Mansoni.

    FavorávelEstudo em AnimaisEsquistossomose
  54. 2014

    Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress.

    FavorávelEstudo em AnimaisDorEstresse OxidativoDor — Polineuropatia Inflamatória
  55. 2014

    Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes

    FavorávelMetanálise ClínicaEsclerose MúltiplaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  56. 2014

    Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence

  57. 2014

    Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  58. 2014

    Potential Effects of Cannabidiol as a Wake-Promoting Agent.

    FavorávelMetanáliseInsônia e Distúrbios do Sono
  59. 2014

    Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies

  60. 2014

    Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder

  61. 2014

    Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations

    FavorávelMetanálise ClínicaDorDor — CrônicaDor — Neuropatia Periférica
  62. 2014

    Priapism in a patient with sickle cell trait using marijuana

    InconclusivoMetanáliseDoença Falciforme
  63. 2014

    Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice.

    FavorávelEstudo em AnimaisAVC
  64. 2014

    Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration.

    FavorávelEstudo em AnimaisDoença Degenerativa do Disco
  65. 2014

    Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoDoenças Neurodegenerativas+3
  66. 2014

    Recurrent myopericarditis as a complication of Marijuana use

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Miocardite
  67. 2014

    Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans

  68. 2014

    Relationship between seminal plasma levels of anandamide congeners palmitoylethanolamide and oleoylethanolamide and semen quality

    DesfavorávelMetanáliseInfertilidade Masculina
  69. 2014

    Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011

  70. 2014

    Repositioning therapy for thyroid cancer: new insights on established medications

    FavorávelMetanáliseCâncerCâncer — Tireoide
  71. 2014

    Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress.

  72. 2014

    Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders

  73. 2014

    Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat

    FavorávelEstudo em AnimaisDorDor — AgudaTetraidrocanabinol (THC)
  74. 2014

    Skin repair properties of d-Limonene and perillyl alcohol in murine models.

    FavorávelEstudo LaboratorialDoenças de PeleDermatite de Contato AlérgicaPsoríase+1
  75. 2014

    Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa

    InconclusivoEstudo em AnimaisAnorexia (perda de apetite)Anorexia Nervosa
  76. 2014

    Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations

  77. 2014

    Substance Use Disorders and Intimate Partner Violence Perpetration among Male and Female Offenders

  78. 2014

    Subtypes Of Attention Deficit-hyperactivity Disorder (ADHD) And Cannabis Use

    FavorávelMetanáliseTDA e TDAH
  79. 2014

    Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome

  80. 2014

    Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports

  81. 2014

    Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.

    FavorávelMetanáliseCâncerCâncer — Cérebro
  82. 2014

    Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology

    FavorávelMetanálise ClínicaDorEpilepsiaEsclerose MúltiplaTHC FarmacêuticoTHC:CBD Farmacêutico+6
  83. 2014

    Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints

  84. 2014

    Targeting Multiple Cannabinoid Anti-tumour Pathways With A Resorcinol Derivative Leads To Inhibition Of Advanced Stages Of Breast Cancer

  85. 2014

    Terpenes Increase the Lipid Dynamics in the Leishmania Plasma Membrane at Concentrations Similar to Their IC50 Values

    FavorávelEstudo LaboratorialLeishmaniose
  86. 2014

    Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages

    FavorávelEstudo LaboratorialInflamaçãoInfecções Bacterianas
  87. 2014

    The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice

  88. 2014

    The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model

    FavorávelEstudo em AnimaisCâncerCâncer — CérebroTetraidrocanabinol (THC)
  89. 2014

    The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients.

    FavorávelEstudo LaboratorialDoença de Huntington
  90. 2014

    The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

    FavorávelEstudo LaboratorialDoença de Parkinson
  91. 2014

    The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC–MS/MS

    DesfavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaEfeitos Adversos do MDMATHC:CBD FarmacêuticoCanabinol (CBN)
  92. 2014

    The Effect of 1,8-Cineole Inhalation on Preoperative Anxiety: A Randomized Clinical Trial

    FavorávelEnsaio ClínicoAnsiedade
  93. 2014

    The effect of a minor constituent of essential oil from Citrus aurantium: the role of β-myrcene in preventing peptic ulcer disease.

    FavorávelEstudo em AnimaisÚlcera Gástrica
  94. 2014

    The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors

  95. 2014

    The Effect of Terpene Combination on Ureter Calculus Expulsion After Extracorporeal Shock Wave Lithotripsy

    FavorávelEnsaio ClínicoCálculos Renais
  96. 2014

    The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.

    FavorávelEstudo LaboratorialCâncer — Mieloma
  97. 2014

    The endocannabinoid system and appetite: relevance for food reward

  98. 2014

    The endocannabinoid system modulates stress, emotionality, and inflammation

    FavorávelMetanáliseInflamação
  99. 2014

    The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells

    FavorávelEstudo LaboratorialInflamaçãoN-Araquidonoil Dopamina (NADA)
  100. 2014

    The Influence Of Cannabinoids On Generic Traits Of Neurodegeneration